Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dentsply SironaXRAY -0.45%59 Equity-to-Asset is 0.26 as of Jun. 2026, which is 52% below its 10-year median of 0.54. GuruFocus rates XRAY with a GF Score™ of 59/100 and a GF Value™ of $17.36 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Dentsply Sirona ranks worse than 86.6% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Dentsply Sirona's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $1,351 Mil. Dentsply Sirona's Total Assets for the quarter that ended in Jun. 2026 was $5,204 Mil.
Therefore, Dentsply Sirona's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.26.
The historical rank and industry rank for Dentsply Sirona's Equity-to-Asset or its related term are showing as below:
XRAY'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.25 Med: 0.54 Max: 0.7
Current: 0.26
During the past 13 years, the highest Equity to Asset Ratio of Dentsply Sirona was 0.70. The lowest was 0.25. And the median was 0.54.
XRAY's Equity-to-Asset is ranked worse than 86.6% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs XRAY: 0.26
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Dentsply Sirona Equity-to-Asset Related Terms
Dentsply Sirona Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Dentsply Sirona's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XRAY vs LMAT, WRBY, PLSE: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Dentsply Sirona's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dentsply Sirona Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dentsply Sirona's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Dentsply Sirona's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Dentsply Sirona's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dentsply Sirona (XRAY) has a Equity-to-Asset of 0.26 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Dentsply Sirona and its competitors. This is 52% below median its historical median of 0.54. Over the past decade, Dentsply Sirona's Equity-to-Asset has ranged from 0.25 to 0.70. According to the industry distribution chart, Dentsply Sirona ranks #737 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 86.6%.
Is Dentsply Sirona's Equity-to-Asset too high?
Dentsply Sirona's current Equity-to-Asset of 0.26 is 52% below median its 10-year median of 0.54. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 0.70. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Dentsply Sirona's value of 0.26 is 59.4% below this industry median. Based on the distribution chart, Dentsply Sirona ranks #737 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Dentsply Sirona has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dentsply Sirona's Equity-to-Asset compare to LMAT and WRBY?
According to the Medical Devices & Instruments industry distribution chart, Dentsply Sirona ranks #737 out of 851 companies for Equity-to-Asset. This places Dentsply Sirona in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Dentsply Sirona's value of 0.26 is 59.4% below this benchmark. Historically, Dentsply Sirona's own Equity-to-Asset has ranged from 0.25 to 0.70 over the past decade. While the company's 10-year median is 0.54 vs. the industry median of 0.64, Dentsply Sirona has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dentsply Sirona's current Equity-to-Asset of 0.26 is 59.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Dentsply Sirona and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dentsply Sirona's current Equity-to-Asset is 0.26, which is 52% below median its own 10-year median of 0.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dentsply Sirona stock overvalued right now?
Based on GuruFocus' analysis, Dentsply Sirona (XRAY) is currently considered Possible Value Trap. The stock's GF Value™ is $17.36, compared to a current price of $11.14 — trading 35.8% below its estimated fair value. The current Equity-to-Asset is 0.26, which is 52% below median its 10-year median of 0.54 and 59.4% below the Medical Devices & Instruments industry median of 0.64. Dentsply Sirona's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Dentsply Sirona (XRAY), the current Equity-to-Asset is 0.26 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dentsply Sirona (XRAY) Overvalued in 2026?
Based on GuruFocus' analysis, Dentsply Sirona stock appears to be undervalued.
The current stock price of $11.14 is trading 35.8% below its estimated GF Value™ of $17.36.
GuruFocus considers Dentsply Sirona to be Possible Value Trap.
Key valuation signals for XRAY:
Equity-to-Asset: 0.26 (52% below median its 10-year median of 0.54)
GF Value™: $17.36 vs. price of $11.14 (35.8% below fair value)
Industry Position: 59.4% below the Medical Devices & Instruments median (#737 of 851)
No single metric tells the full story. See the XRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
59GF Score
Get the complete analysis for XRAY
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XRAY has been successfully added to your 
